The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large b-cell lymphoma (DLBCL) treated with R-CHOP: A study in a genetically mixed population

Clinics

Volumn 66, Issue 5, 2011, Pages 919-922

  Levy, Débora ^a   Bellesso, Marcelo ^a,b   Oliveira Souza, Pamela ^a   Maciel, Felipe V ^a,b   Pereira, Juliana ^a,b   Bydlowski, Sérgio P ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Criminalistic Institute of Sao Paulo   (Brazil)

^c FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960752894     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000500034     Document Type: Article

References (15)

1. Hallack Neto AE, Pereira J, Beitler B, Chamone DAF, Llacer PD, Dulley FL, et al. Results of CHOP chemotherapy for diffuse large B-cell lymphoma. Brazilian Journal of Medical and Biological Research. 2006;39:1315-22 doi: 10.1590/S0100-879X2006001000007.
2. Golay J, Zaffaroni L, Vaccari T, Lazzari M, Borleri GM, Bernasconi S, et al. Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complementmediated cell lysis. Blood. 2000;95:3900-08.
3. Cohen-Solal JF, Cassard L, Friedman WH, Sautes-Friedman C. Fc gamma receptors. Immunology Letters. 2004; 92:199-205 doi: 10.1016/j.imlet. 2004.01.012.
4. van der Pol WL, Jansen MD, Sluiter WJ, van de Sluis B, Leppers-van de Straat FG, Kobayashi T, et al. Evidence for non-random distribution of Fcc receptor genotype combinations. Immunogenetics 2003;55:240-6 doi: 10.1007/s00251-003-0574-9.
5. Carlotti E, Palumbo GA, Oldani E, Tibullo D, Salmoiraghi S, Rossi A, et al. FccRIIIA and FccRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab. Haematologica. 2007;92:1127-30 doi: 10.3324/haematol.11288.
6. Weng W-K, Levy R. Immunoglobulin G Fc receptor polymorphisms do not correlate with response to chemotherapy or clinical course in patients with follicular lymphoma. Leukemia & Lymphoma. 2009; 50:1494-500 doi: 10.1080/10428190903128660.
7. Paiva M, Marques H, Martins A, Ferreira P, Catarino R, Medeiros R. FcgRIIa polymorphism and clinical response to rituximab in non-Hodgkin lymphoma patients. Cancer Genetics and Cytogenetics. 2008;183:35-40 doi: 10.1016/j.cancergencyto.2008.02.001.
8. Mitroviç Z, Aurer I, Radman I, Ajdukoviç R, Sertiç J, Labar B. FCγRIIIA and FCcRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large Bcell lymphoma. Haematologica. 2007;92:998-9 doi: 10.3324/haematol. 10327.
9. Gonçalves VF, Carvalho CMB, Bortolini MC, Bydlowski SP, Pena SDJ. The phylogeography of African Brazilians. Human Heredy. 2008; 65:23-32 doi: 10.1159/000106059.
10. Pena SDJ, Bastos-Rodrigues L, Pimenta JR, Bydlowski SP. DNA tests probe the genomic ancestry of Brazilians. Brazilian Journal of Medical and Biological Research. 2009;42:870-6 doi: 10.1590/S0100-879X2009005000026.
11. Cheson BD, Pfistner B, Juweid ME, Gayscone RD, Specht L, Horning SJ, et al. International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. Journal of Clinical Oncology. 2007;25:579-86.
12. Bydlowski SP, Novak EM, Issa JS, Forti N, Giannini SD, Diament J. DNA polymorphisms of apolipoprotein B and AI-CIII-AIV genes in a Brazilian population. A preliminary report. Brazilian Journal of Medical and Biological Research. 1996;29:1269-74.
13. Novak EM, Metzger M, Chammas R, da Costa M, Dantas K, Manabe C, et al. Downregulation of TNF-a and VEGF expression by Sp1 decoy oligonucleotides in mouse melanoma tumor. Gene Therapy. 2003;10:1992-7 doi: 10.1038/sj.gt.3302111.
14. Jiang XM, Arepally G, Poncz M, McKenzie SE. Rapid detection of the FcγRIIa - H/R 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED). Journal of Immunological Methods. 1996;199:55-9 doi: 10.1016/S0022-1759(96)00164-0.
15. Weiner GJ. Rituximab: Mechanism of Action. Seminars in Hematology. 2010;47:115-23 doi: 10.1053/j.seminhematol.2010.01.011.